Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
-0.49%
)
US TECH 100
26,396.80
(
0.36%
)
Dow Jones
49,141.93
(
0.00%
)
Brent Oil
107.21
(
2.68%
)
Bitcoin
77,608.01
(
1.65%
)
News Focus
News Focus
Post# of 5031211
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Peter2004

Send PM Follow Ignore
Followers 16
Posts 4726
Boards Moderated 0
Alias Born 12/06/2005

Peter2004

Re: None

Monday, 06/29/2009 9:13:56 AM

Monday, June 29, 2009 9:13:56 AM

Post# of 5031211
WOW. GNBT is going to rock star. SA' diabetes drug, Lantus, appears to have a link to cancer. More information will come out today. Generex has it's orally sprayed insulin, Ora-lyn in PH III trials. Lantus, among others, are competitors to Ora-lyn. Many of these competitors are falling by the wayside due to side effects. To date Ora-lyn has proven to be efficacious as well as safe. Approximately 375 people have already participated in the PH III trials. This is the connection.

This is all my own opinion only. Please do your own DD before you buy or sell this stock

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today